查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1523148

藥物發現技術市場報告：2030 年趨勢、預測與競爭分析

Drug Discovery Technology Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

藥物發現技術的趨勢和預測

到 2030 年，全球藥物發現技術市場預計將達到 1,235 億美元，2024 年至 2030 年複合年成長率為 9.1%。該市場的主要驅動力是慢性病的流行、藥品消費的增加、研發投資的增加以及技術的快速發展。全球藥物發現科技市場的未來充滿希望，製藥、生物製藥、生技和研究機構市場充滿機會。

藥物發現技術的細分市場

該研究包括按技術、應用、最終用途行業、技術和地區對全球藥物發現技術的預測。

藥物發現技術市場洞察

Lucintel 預測，高通量篩檢將在預測期內呈現最高成長。這是因為它作為一種藥物發現方法在製藥業被廣泛採用，可以快速測試許多物質的生物或生化活性。

由於大量國際公司大力投資生物製藥研發，生物製藥公司可能仍是市場上最大的部分。

由於健康意識的提高、公共和私人醫療保健支出的增加以及生物技術和製藥行業個性化醫療的興起，對藥物發現技術的需求不斷增加，預計北美在預測期內將經歷最高的成長。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球藥物發現技術市場預計將達到 1,235 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球藥物發現技術市場預計將以9.1%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3.該市場的主要促進因素是慢性病的增加、藥品消費的增加、研發投資的增加以及技術的快速發展。

Q4.市場的主要細分市場是：

A4. 全球藥物發現技術市場未來性廣闊，製藥、生物製藥、生技和研究機構市場充滿機會。

Q5.市場的主要企業是：

A5. 主要的藥物發現技術公司是：

  • Abbott Laboratories
  • Affymetrix
  • Agilent Technologies
  • Albany Molecular Research
  • ArQule
  • AstraZeneca
  • Bio-Rad Laboratories
  • Caliper Life Sciences
  • Celera
  • Charles River Laboratories

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，高通量篩檢將在預測期內達到最高成長。這是因為高通量篩檢作為藥物發現方法在製藥業被廣泛採用，可以快速測試許多物質的生物或生化活性。

Q7.未來五年預計哪個地區的市場成長最大？

A7. 由於健康意識的提高、公共和私人醫療保健支出的增加以及生物技術和製藥行業個性化醫療的興起，對藥物發現技術的需求不斷增加，預計北美將在預測期內實現最高的成長。 。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球藥物發現技術市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球藥物發現技術市場趨勢（2018-2023）與預測（2024-2030）
  • 按技術分類的全球藥物發現技術市場
    • 高通量篩檢
    • 基因組學
    • 生物晶片
    • 藥物基因組學
    • 生物分析設備
    • 生物資訊學
    • 奈米科技
    • 其他
  • 按應用分類的全球藥物發現技術市場
    • 心血管疾病
    • 帕金森氏症
    • 阿茲海默症
    • 其他
  • 按最終用途行業分類的全球藥物發現技術市場
    • 製藥公司
    • 生物製藥公司
    • 生技公司
    • 研究所

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球藥物發現技術市場
  • 北美藥物發現技術市場
  • 歐洲藥物發現技術市場
  • 亞太藥物發現技術市場
  • 其他地區的藥物發現技術市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球藥物發現技術市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球藥物發現技術市場的能力
    • 全球藥物發現技術市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Abbott Laboratories
  • Affymetrix
  • Agilent Technologies
  • Albany Molecular Research
  • ArQule
  • AstraZeneca
  • Bio-Rad Laboratories
  • Caliper Life Sciences
  • Celera
  • Charles River Laboratories
簡介目錄

Drug Discovery Technology Trends and Forecast

The future of the global drug discovery technology market looks promising with opportunities in the pharmaceutical company, biopharmaceutical company, biotech company, and research institute markets. The global drug discovery technology market is expected to reach an estimated $123.5 billion by 2030 with a CAGR of 9.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, rising consumption of pharmaceutical drugs, as well as, growing investments in R&D and rapid technological development.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Drug Discovery Technology by Segment

The study includes a forecast for the global drug discovery technology by technology, application, end use industry, tech, and region.

Drug Discovery Technology Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • High Throughput Screening
  • Genomics
  • Biochips
  • Pharmacogenomics
  • Bioanalytical Instruments
  • Bioinformatics
  • Nanotechnology
  • Others

Drug Discovery Technology Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular Diseases
  • Parkinson's
  • Alzheimer's
  • Others

Drug Discovery Technology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Biotech Companies
  • Research Institutes

Drug Discovery Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Drug Discovery Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discovery technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discovery technology companies profiled in this report include-

  • Abbott Laboratories
  • Affymetrix
  • Agilent Technologies
  • Albany Molecular Research
  • ArQule
  • AstraZeneca
  • Bio-Rad Laboratories
  • Caliper Life Sciences
  • Celera
  • Charles River Laboratories

Drug Discovery Technology Market Insights

Lucintel forecasts that high throughput screening is expected to witness the highest growth over the forecast period because it extensively employed in the pharmaceutical business as a method of drug discovery, and it enables a rapid test of many substances' biological or biochemical activities.

Within this market, biopharmaceutical company will remain the largest segment because it comprises a large number of international companies that invest heavily in biopharmaceutical medication research and development.

North America is expected to witness the highest growth over the forecast period due to growing emphasis on wellbeing and health, rising public and private healthcare spending, along with the region's biotech and pharmaceutical industries seeing a rise in demand for drug discovery technologies owing to the rise of personalized medications.

Features of the Global Drug Discovery Technology Market

Market Size Estimates: Drug discovery technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Drug discovery technology market size by technology, application, end use industry, tech, and region in terms of value ($B).

Regional Analysis: Drug discovery technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, application, end use industry, tech, and regions for the drug discovery technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug discovery technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug discovery technology market size?

Answer: The global drug discovery technology market is expected to reach an estimated $123.5 billion by 2030.

Q2. What is the growth forecast for drug discovery technology market?

Answer: The global drug discovery technology market is expected to grow with a CAGR of 9.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the drug discovery technology market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases, rising consumption of pharmaceutical drugs, as well as, growing investments in R&D and rapid technological development.

Q4. What are the major segments for drug discovery technology market?

Answer: The future of the global drug discovery technology market looks promising with opportunities in the pharmaceutical company, biopharmaceutical company, biotech company, and research institute markets.

Q5. Who are the key drug discovery technology market companies?

Answer: Some of the key drug discovery technology companies are as follows:

  • Abbott Laboratories
  • Affymetrix
  • Agilent Technologies
  • Albany Molecular Research
  • ArQule
  • AstraZeneca
  • Bio-Rad Laboratories
  • Caliper Life Sciences
  • Celera
  • Charles River Laboratories

Q6. Which drug discovery technology market segment will be the largest in future?

Answer: Lucintel forecasts that high throughput screening is expected to witness the highest growth over the forecast period because it extensively employed in the pharmaceutical business as a method of drug discovery, and it enables a rapid test of many substances' biological or biochemical activities.

Q7. In drug discovery technology market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period due to growing emphasis on wellbeing and health, rising public and private healthcare spending, along with the region's biotech and pharmaceutical industries seeing a rise in demand for drug discovery technologies owing to the rise of personalized medications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the drug discovery technology market by technology (high throughput screening, genomics, biochips, pharmacogenomics, bioanalytical instruments, bioinformatics, nanotechnology, and others), application (cardiovascular diseases, Parkinson's, Alzheimer's, and others), end use industry (pharmaceutical companies, biopharmaceutical companies, biotech companies, and research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Drug Discovery Technology Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Drug Discovery Technology Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Drug Discovery Technology Market by Technology
    • 3.3.1: High Throughput Screening
    • 3.3.2: Genomics
    • 3.3.3: Biochips
    • 3.3.4: Pharmacogenomics
    • 3.3.5: Bioanalytical Instruments
    • 3.3.6: Bioinformatics
    • 3.3.7: Nanotechnology
    • 3.3.8: Others
  • 3.4: Global Drug Discovery Technology Market by Application
    • 3.4.1: Cardiovascular Diseases
    • 3.4.2: Parkinson's
    • 3.4.3: Alzheimer's
    • 3.4.4: Others
  • 3.5: Global Drug Discovery Technology Market by End Use Industry
    • 3.5.1: Pharmaceutical Companies
    • 3.5.2: Biopharmaceutical Companies
    • 3.5.3: Biotech Companies
    • 3.5.4: Research Institutes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Drug Discovery Technology Market by Region
  • 4.2: North American Drug Discovery Technology Market
    • 4.2.1: North American Drug Discovery Technology Market by Technology: High throughput screening, Genomics, Biochips, Pharmacogenomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others
    • 4.2.2: North American Drug Discovery Technology Market by End Use Industry: Pharmaceutical companies, Biopharmaceutical companies, Biotech companies, and Research Institutes
  • 4.3: European Drug Discovery Technology Market
    • 4.3.1: European Drug Discovery Technology Market by Technology: High throughput screening, Genomics, Biochips, Pharmacogenomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others
    • 4.3.2: European Drug Discovery Technology Market by End Use Industry: Pharmaceutical companies, Biopharmaceutical companies, Biotech companies, and Research Institutes
  • 4.4: APAC Drug Discovery Technology Market
    • 4.4.1: APAC Drug Discovery Technology Market by Technology: High throughput screening, Genomics, Biochips, Pharmacogenomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others
    • 4.4.2: APAC Drug Discovery Technology Market by End Use Industry: Pharmaceutical companies, Biopharmaceutical companies, Biotech companies, and Research Institutes
  • 4.5: ROW Drug Discovery Technology Market
    • 4.5.1: ROW Drug Discovery Technology Market by Technology: High throughput screening, Genomics, Biochips, Pharmacogenomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others
    • 4.5.2: ROW Drug Discovery Technology Market by End Use Industry: Pharmaceutical companies, Biopharmaceutical companies, Biotech companies, and Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Drug Discovery Technology Market by Technology
    • 6.1.2: Growth Opportunities for the Global Drug Discovery Technology Market by Application
    • 6.1.3: Growth Opportunities for the Global Drug Discovery Technology Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Drug Discovery Technology Market by Region
  • 6.2: Emerging Trends in the Global Drug Discovery Technology Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Drug Discovery Technology Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discovery Technology Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Affymetrix
  • 7.3: Agilent Technologies
  • 7.4: Albany Molecular Research
  • 7.5: ArQule
  • 7.6: AstraZeneca
  • 7.7: Bio-Rad Laboratories
  • 7.8: Caliper Life Sciences
  • 7.9: Celera
  • 7.10: Charles River Laboratories